NASDAQ:BNGO Bionano Genomics Q3 2026 Earnings Date & Estimates $1.20 -0.06 (-4.40%) Closing price 03:59 PM EasternExtended Trading$1.18 -0.02 (-1.26%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Bionano Genomics is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Bionano Genomics in Q3 2026Bionano Genomics is expected to post earnings of -$0.45 per share on revenue of $8.44 million. In the same quarter a year earlier Bionano Genomics reported -$1.59 per share on revenue of $7.37 million. Bionano Genomics last reported on August 10, 2026, posting -$0.64 per share and beating the -$0.67 consensus estimate. Bionano Genomics has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.45Expected Revenue$8.44 millionPrior-Year EPS-$1.59Prior-Year Revenue$7.37 millionExpected Revenue Growth+14.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.64 (Beat by +$0.03)Last Quarter Revenue($6.67) millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Bionano Genomics Q3 2026 Earnings FAQ When does Bionano Genomics report Q3 2026 earnings? Bionano Genomics (NASDAQ:BNGO) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Bionano Genomics' Q3 2026 earnings call? Bionano Genomics' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Bionano Genomics? Analysts expect Bionano Genomics to post earnings of -$0.45 per share for Q3 2026. How much revenue is Bionano Genomics expected to report? The consensus revenue estimate for Bionano Genomics is $8.44 million for Q3 2026. When is Bionano Genomics' next earnings date? Bionano Genomics' next earnings date is estimated for Thursday, October 29, 2026. MarketBeat tracks confirmed and estimated earnings dates for Bionano Genomics on the company's earnings history page. Bionano Genomics Earnings HeadlinesBionano Genomics consensus price target increased by 21.14% to MX$100.98October 4, 2026 | msn.comBionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic MalignanciesSeptember 23, 2026 | globenewswire.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 22 at 1:00 AM | Weiss Ratings (Ad)Bionano: OGM Studies Reveal High-Risk Genomic Alterations Missed By Standard CytogeneticsSeptember 14, 2026 | rttnews.comBionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid LeukemiaSeptember 14, 2026 | globenewswire.comBionano Announces Proposed Medicare Coverage For Genome-Wide Hematologic Cancer TestingSeptember 10, 2026 | rttnews.comSee More Bionano Genomics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bionano Genomics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bionano Genomics and other key companies, straight to your email. Email Address About Bionano GenomicsBionano Genomics (NASDAQ:BNGO) is a life sciences company that develops genomic analysis solutions based on optical genome mapping (OGM). Its technology is designed to identify structural variations and other genomic abnormalities that may be difficult to detect with traditional sequencing and cytogenetic methods. The company’s principal platform is the Saphyr system, which includes instrumentation, consumables and software for analyzing ultra-long DNA molecules. Bionano also provides data-analysis tools and informatics solutions intended to support research and clinical workflows in areas such as constitutional genetics, oncology and hematologic malignancies. Bionano Genomics serves academic, government, pharmaceutical and biotechnology researchers, as well as clinical laboratories in the United States and international markets. The company was founded in 2003 and is headquartered in San Diego, California. Its leadership has included Erik Holmlin, who has served as president and chief executive officer.View Bionano Genomics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Texas Paused Data Center Hookups—2 Power Stocks Are Waiting on the VerdictIs Texas Instruments Setting Up for Its Next Big Breakout?Lam Research's Earnings Beat Wasn't the Real Story—Its 2027 Outlook WasTesla’s Flying-Car Hype Hits an Earnings Reality CheckMeta Bounces Back in Q3, But the Bigger Test Comes in 2027Cologuard Is Working—So Why Isn’t Abbott Stock?Pegasystems' Q3 Miss Exposed the Problem Standing Between AI and Cash Flow Upcoming Earnings ENI (10/23/2026)SLB (10/23/2026)American Express (10/23/2026)Infosys (10/23/2026)Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
